ArticleCureus2026
Recurrent Symptomatic Renal Angiomyolipoma After Selective Arterial Embolization: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A middle-aged woman with a history of a large right renal angiomyolipoma (AML), previously treated with selective arterial embolization, presented to our facility with a sudden onset of recurrent right-sided abdominal pain. Despite a prolonged asymptomatic period following her initial procedure, clinical evaluation and laboratory testing were initiated to investigate the recurrence. Cross-sectional imaging revealed an increase in the size of the residual mass and areas of hyperdensity, suggesting minor recurrent hemorrhage. Subsequent digital subtraction angiography was performed, which provided a definitive characterization of the vascular supply, demonstrating partial recanalization of previously embolized vessels and a prominent residual tumor blush. Following a multidisciplinary review, the patient underwent a repeat selective arterial embolization. The procedure was successful, achieving total devascularization of the target area. Post procedure, the patient experienced complete symptom resolution. Long-term follow-up confirmed sustained clinical stability and radiological improvement, demonstrating that repeat embolization is an effective nephron-sparing strategy for managing late-stage recanalization in renal AML.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.